Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian P Gee

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2007
Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survivalMary Eapen, Brent R Logan, Dennis L Confer, et al.
Investigational New Drugs|April 24, 2013
HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancerGuru Sonpavde, Mingjun Wang, Leif E Peterson, et al.
Blood|November 16, 2004
Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytesKarin C M Straathof, Catherine M Bollard, Uday Popat, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2011
Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignanciesJakob R Passweg, Mei-Jie Zhang, Vanderson Rocha, et al.
Blood|October 31, 2008
Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patientsChrystal U Louis, Karin Straathof, Catherine M Bollard, et al.
Blood|October 24, 2002
Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infectionBarbara Savoldo, M Helen Huls, Zhensheng Liu, et al.
Transfusion|January 28, 2009
Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapiesWilliam Reed, Stephen J Noga, Adrian P Gee, et al.
Science Translational Medicine|June 27, 2014
Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCTAnastasia Papadopoulou, Ulrike Gerdemann, Usha L Katari, et al.
Blood|September 29, 2018
EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantationLauren P McLaughlin, Rayne Rouce, Stephen Gottschalk, et al.
The Journal of Clinical Investigation|May 5, 2011
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patientsBarbara Savoldo, Carlos Almeida Ramos, Enli Liu, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2007
Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survivalMary Eapen, Brent R Logan, Dennis L Confer, et al.
Investigational New Drugs|April 24, 2013
HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancerGuru Sonpavde, Mingjun Wang, Leif E Peterson, et al.
Blood|November 16, 2004
Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytesKarin C M Straathof, Catherine M Bollard, Uday Popat, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2011
Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignanciesJakob R Passweg, Mei-Jie Zhang, Vanderson Rocha, et al.
Blood|October 31, 2008
Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patientsChrystal U Louis, Karin Straathof, Catherine M Bollard, et al.
Blood|October 24, 2002
Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infectionBarbara Savoldo, M Helen Huls, Zhensheng Liu, et al.
Transfusion|January 28, 2009
Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapiesWilliam Reed, Stephen J Noga, Adrian P Gee, et al.
Science Translational Medicine|June 27, 2014
Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCTAnastasia Papadopoulou, Ulrike Gerdemann, Usha L Katari, et al.
Blood|September 29, 2018
EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantationLauren P McLaughlin, Rayne Rouce, Stephen Gottschalk, et al.
The Journal of Clinical Investigation|May 5, 2011
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patientsBarbara Savoldo, Carlos Almeida Ramos, Enli Liu, et al.
Pageof 9